Regulation of hepatic gene expression by saturated fatty acids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 82, Issue 4-6, 2010, Pages 211-218

  Vallim, T ^a,b   Salter, A M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOWN REGULATION; FAT INTAKE; GENE EXPRESSION REGULATION; HUMAN; LIGAND BINDING; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; LIVER METABOLISM; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; THERAPY EFFECT;

ANIMALS; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; GENE EXPRESSION REGULATION; HUMANS; LIVER; ORPHAN NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; STEROL REGULATORY ELEMENT BINDING PROTEINS;

EID: 77951975525     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2010.02.016     Document Type: Article

References (78)

1. Jump D.B. n-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 2008, 19:242-247.
2. Salter A.M., Tarling E.J. Regulation of gene transcription by fatty acids. Animal 2007, 1:1314-1320.
3. Sampath H., Ntambi J. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 2005, 25:317-340.
4. Packard C.J., Shepherd J. Physiology of the lipoprotein transport system: an overview of lipoprotein metabolism. Lipoproteins in Health and Disease 1999, 3-316. Arnold, London. D.J. Betteridge, D.R. Illingworth, J. Shepherd (Eds.).
5. Salter A.M., Mangiapane E.H. The lipoproteins. Diet, Lipoprotein and Coronary Heart Disease: A Biochemical Perspective 1999, Nottingham University Press, Nottingham, pp. 41-66.
6. Babin P.J., Gibbons G.F. The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism. Prog. Lipid Res. 2009, 48:73-91.
7. Rye K.-A., Bursill C.A., Lambert G., Tabet F., Barter P.J. The metabolism and ant-atherogenic properties of HDL. J. Lipid Res. 2009, 50:S195-S200.
8. White D.A., Bennett A.J., Billett M.A., Salter A.M. The assembly of triacylglycerol-rich lipoproteins; an essential role for the microsomal triacylglycerol transfer protein. Br. J. Nutr. 1998, 80:219-229.
9. Gambino R., Cassader M., Pagano G., Durazzo M., Musso G. Polymophism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH. Hepatology 2007, 45:1097-1107.
10. J. Ye, J.Z. Li, Y. Liu et al., Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B, Cell Metab. 9 (2009) 177-190.
11. Hussain M.M., Strickland D.K., Bakillah A. The mammalian low-density lipoprotein receptor family. Annu. Rev. Nutr. 1999, 19:141-172.
12. Trigatti T.B., Kreiger M., Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1732-1738.
13. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells and blood. Proc. Natl. Acad. Sci. USA 1999, 96:11041-11048.
14. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete programme of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
15. Salter A.M., White D.A. Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentrations. Nutr. Res. Rev. 1996, 9:241-257.
16. Anon, The diet and all-causes death rate in the Seven Countries Study, Lancet 318 (8237) (1981) 57-61.
17. Keys A., Anderson J.T., Grande F. Serum cholesterol response to changes in diet IV. Particular saturated fatty acids in the diet. Metabolism 1965, 14:776-787.
18. Hegsted D.M., McGandy R.B., Myers M.L., Stare F.J. Quantitative effects of dietary fat on serum cholesterol in man. Am. J. Clin. Nutr. 1965, 17:281-295.
19. Mensink R.P., Katan M.B. Effects of dietary fatty acids on serum lipds and lipoproteins. A meta-analysis of 27 trials. Arterioscler. Thromb. 1992, 12:911-919.
20. Mensink R.P., Zock P.L., Kester A.D.M., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins,: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77:1146-1155.
21. Preiss D., Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin. Sci. 2008, 115:141-150.
22. Musso G., Gambino R., Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 2009, 48:1-26.
23. Byrne C.D., Olufadi R., Bruce K.D., Cagampang F.R., Ahmed M.H. Metabolic disturbances in non-alcoholic fatty liver disease. Clin. Sci. 2009, 116:539-564.
24. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
25. Rector R.S., Thyfault J.P., Wei Y., Ibdah J.A. Non-alcoholic fatty liver disease and the metabolic syndrome:an update. World J. Gastroenterol. 2008, 14:185-192.
26. Tiniakos D.G., Vos M.B., Brunt E.M. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. Mech. Dis. 2010, 5:145-171.
27. Day C.P., James O.F. Steatohepatitis: a tale of two "hits"?. Gastroenterology 1998, 114:842-845..
28. Malaguarnera M., Di Rosa M., Nicoletti F., Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J. Mol. Med. 2009, 87:679-695.
29. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004, 109:433-438.
30. Donnelly K.L., Smith C.I., Schearzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non-alcoholic fatty liver disease. J. Clin. Invest. 2005, 115:1343-1351.
31. Oosterveer M.H., van Dijk T.H., Tietge U.J.F., et al. High fat feeding induces hepatic fatty acid elongation in mice. PLoS ONE 2009, 4(6):e6066.
32. Lin J., Yang R., Tarr P.T., et al. Hyerlipidemic effects of dietary saturated fats mediated through PGC-1Β coactivation of SREBP. Cell 2005, 120:261-273.
33. Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase-1 mediates the prolipogenic effects of dietary saturated fat. J. Biol. Chem. 2007, 282:2483-2493.
34. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
35. Desvergne B., Wahli W. Peroxisome proliferators-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
36. Brown J.D., Plutzky J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007, 115:518-533.
37. Krey G., Braissant O., L'Horset F., et al. Fatty acids, eicosanoids, and hypolipidemic agents identified a sligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 1997, 11:779-791.
38. Kliewer S.A., Sundeth S.S., Jones S.A., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and Β. Proc. Natl. Acad. Sci. USA 1997, 94:4318-4323.
39. Chakravarthy M.V., Lodhi I.J., Yin L., et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009, 138:476-488.
40. Janowski B.A., Grogan M.J., Jones SA S.A., et al. Structural requirements of ligands for the oxysterol liver X receptors, LXRα and LXR®. Proc. Natl. Acad. Sci. 1999, 96:266-271.
41. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 2000, 16:459-481.
42. Geyeregger R., Zeyda M., Stulnig T.M. Liver X receptors in cardiovascular and metabolic disease. Cell. Mol. Life Sci. 2006, 63:524-539.
43. Peet D.J., Turley S.D., Ma W., et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 1998, 93:693-704.
44. Laffitte B.A., Chao L.C., Li J., et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA 2003, 100:5419-5424.
45. Cao G., Liang Y., Broderick C.L., et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 2003, 278:1131-1136.
46. Zelcer N., Hong C., Boyadjian R., Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
47. Hannah V.C., Ou J., Luong A., Goldstein J.L., Brown M.S. Unsaturated fatty acids downregulate SREBP isoforms 1a and 1c by two mechanisms. J. Biol. Chem. 2001, 276:4365-4372.
48. Yoshikawa T., Shimano H., Amemiya-Kudo M., et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 2001, 21:2991-3000.
49. Yoshikawa T., Shimano H., Yahagi N., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 2002, 277:1705-1711.
50. Brown MS M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells and blood. Proc. Natl. Acad. Sci. USA 1999, 96:11041-11048.
51. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete programm of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
52. Eberlé D., Hegarty B., Bossard P., Ferré P., Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004, 86:839-848.
53. Goldstein JL J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
54. Sun L-P L.-P., Li L., Goldstein J.L., Brown M.S. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J. Biol. Chem. 2005, 280:26483-26490.
55. Nohturfft A., Yabe D., Goldstein J.L., Brown M.S., Espenshade P.J. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 2000, 102:315-323.
56. Yang T., Espenshade P.J., Wright M.E., Yabe D., Gong Y., Aebersold R., Goldstein J.L., Brown MS M.S. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs to the ER. Cell 2002, 110:489-500.
57. Lange Y., Steck T.L., Ye J., Lanier M.H., Molugu V., Ory D. Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol. J. Lipid Res. 2009, 50:1881-1888.
58. Radhakrishnan A., Goldstein J.L., McDonald J.G., Brown M.S. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008, 8:512-521.
59. Sheng Z., Otani H., Brown M.S., Goldstein J.L. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc. Natl. Acad. Sci. USA 1995, 92:935-938.
60. Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J.L., Shimano N. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 2000, 101:2331-2339.
61. Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S., Goldstein J.L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 1996, 98:1575-1584.
62. Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S., Goldstein J.L. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest. 1997, 99:846-854.
63. Horton J.D., Bashmakov Y., Shimomura I., Shimano H H. Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc. Natl. Acad. Sci. USA 1998, 95:5987-5992.
64. Worgall T.S., Sturley S.L., Soe T., Osborne T.F., Deckelbaum R.J. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of sterol regulatory element binding protein. J. Biol. Chem. 1998, 273:23537-23540.
65. Hannah V.C., Ou J., Luong A., Goldstein J.L., Brown M.S. Unsaturated fatty acids downregulate SREBP isoforms 1a and 1c by two mechanisms. J. Biol. Chem. 2001, 276:4365-4372.
66. Yoshikawa T., Shimano H., Amemiya-Kudo M., et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol. Cell. Biol. 2001, 21:2991-3000.
67. Yoshikawa T., Shimano H., Yahagi N., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 2002, 277:1705-1711.
68. Tarling E., Salter A., Bennett A. Transcriptional regulation of human SREBP-1c (sterol-regulatory-element-binding protein-1c): a key regulator of lipogenesis. Biochem. Soc. Trans. 2004, 32:107-109.
69. Yoshikawa T., Ide T., Shimano H., et al. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signalling. Mol. Endocrinol. 2003, 17:1240-1254.
70. Botolin D., Wang Y., Christian B., Jump D.B. Docosahexaenoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways. J. Lipid Res. 2006, 47:181-192.
71. Woollett L.A., Spady D.K., Dietschy J.M. Regulatory effects of the saturated fatty acids 6:0 through 18:0 on hepatic low density lipoprotein receptor activity in the hamster. J. Clin. Invest. 1992, 89:1133-1141.
72. Spady D.K., Woollett L.A., Dietschy J.M. Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu. Rev. Nutr. 1993, 13:355-381.
73. Bennett A.J., Billett M.A., Salter A.M., et al. Modulation of hepatic apolipoprotein-b, 3-hydroxy-3-methylglutaryl-coa reductase and low-density-lipoprotein receptor messenger-RNA and plasma-lipoprotein concentrations by defined dietary fats-comparison of trimyristin, tripalmitin, tristerin and triolein. Biochem. J. 1995, 311:167-173.
74. Salter A.M., Mangiapane E.H., Bennett A.J., et al. The effect of different dietary fatty acids on lipoprotein metabolism: concentration-dependent effects of diets enriched in oleic, myristic, palmitic and stearic acids. Br. J. Nutr. 1998, 79:195-202.
75. Anstee Q.M., Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatisis research. Int. J. Exp. Pathol. 2006, 87:1-16.
76. Daumerie C.M., Woollett L.A., Dietschy J.M. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc. Natl. Acad. Sci. USA 1992, 89:10797-10801.
77. Datta S., Osborne T.F. Activation domains from both monomers contribute to transcriptional stimulation of sterol regulatory element-binding protein dimmers. J. Biol. Chem. 2005, 280:3338-3345.
78. Bennett M.K., Seo Y.-K., Datta S., Shin D.-J., Osborne T.F. Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver. J. Biol. Chem. 2008, 283:15628-15637.